These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 30974904)

  • 1. Empowering Mesenchymal Stem Cells for Ocular Degenerative Disorders.
    Ding SSL; Subbiah SK; Khan MSA; Farhana A; Mok PL
    Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30974904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenchymal Stem Cell-Based Therapy for Retinal Degenerative Diseases: Experimental Models and Clinical Trials.
    Holan V; Palacka K; Hermankova B
    Cells; 2021 Mar; 10(3):. PubMed ID: 33799995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular Reparative Mechanisms of Mesenchymal Stem Cells for Retinal Diseases.
    Ding SLS; Kumar S; Mok PL
    Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28788088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Promising Tool in Retina Regeneration: Current Perspectives and Challenges When Using Mesenchymal Progenitor Stem Cells in Veterinary and Human Ophthalmological Applications.
    Cislo-Pakuluk A; Marycz K
    Stem Cell Rev Rep; 2017 Oct; 13(5):598-602. PubMed ID: 28643176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal stromal/stem cells as potential therapy in diabetic retinopathy.
    Fiori A; Terlizzi V; Kremer H; Gebauer J; Hammes HP; Harmsen MC; Bieback K
    Immunobiology; 2018 Dec; 223(12):729-743. PubMed ID: 29402461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinal and optic nerve diseases.
    Margalit E; Sadda SR
    Artif Organs; 2003 Nov; 27(11):963-74. PubMed ID: 14616515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concise Review: Patient-Specific Stem Cells to Interrogate Inherited Eye Disease.
    Giacalone JC; Wiley LA; Burnight ER; Songstad AE; Mullins RF; Stone EM; Tucker BA
    Stem Cells Transl Med; 2016 Feb; 5(2):132-40. PubMed ID: 26683869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [On the preliminary results of the use of hyperbaric oxygenation in ocular pathology].
    Algan B; Benichoux R; Marchal H
    Bull Soc Belge Ophtalmol; 1973 Feb; 163(2):183-94. PubMed ID: 4758854
    [No Abstract]   [Full Text] [Related]  

  • 9. Genetically-modified human mesenchymal stem cells to express erythropoietin enhances differentiation into retinal photoreceptors: An in-vitro study.
    Ding SLS; Koh AE; Kumar S; Ali Khan MS; Alzahrani B; Mok PL
    J Photochem Photobiol B; 2019 Jun; 195():33-38. PubMed ID: 31060031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine interplay among the diseased retina, inflammatory cells and mesenchymal stem cells - a clue to stem cell-based therapy.
    Holan V; Hermankova B; Krulova M; Zajicova A
    World J Stem Cells; 2019 Nov; 11(11):957-967. PubMed ID: 31768222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal stem cells and potential applications in treating ocular disease.
    Joe AW; Gregory-Evans K
    Curr Eye Res; 2010 Nov; 35(11):941-52. PubMed ID: 20958182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atorvastatin: an efficient step forward in mesenchymal stem cell therapy of diabetic retinopathy.
    Mottaghi S; Larijani B; Sharifi AM
    Cytotherapy; 2013 Mar; 15(3):263-6. PubMed ID: 23253439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel stem cell and gene therapy in diabetic retinopathy, age related macular degeneration, and retinitis pigmentosa.
    Ludwig PE; Freeman SC; Janot AC
    Int J Retina Vitreous; 2019; 5():7. PubMed ID: 30805203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal Stem Cells and Cancer: Clinical Challenges and Opportunities.
    Lin W; Huang L; Li Y; Fang B; Li G; Chen L; Xu L
    Biomed Res Int; 2019; 2019():2820853. PubMed ID: 31205939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraocular pressure reduction and neuroprotection conferred by bone marrow-derived mesenchymal stem cells in an animal model of glaucoma.
    Roubeix C; Godefroy D; Mias C; Sapienza A; Riancho L; Degardin J; Fradot V; Ivkovic I; Picaud S; Sennlaub F; Denoyer A; Rostene W; Sahel JA; Parsadaniantz SM; Brignole-Baudouin F; Baudouin C
    Stem Cell Res Ther; 2015 Sep; 6(1):177. PubMed ID: 26377305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regenerative treatment of ophthalmic diseases with stem cells: Principles, progress, and challenges.
    Niu Y; Ji J; Yao K; Fu Q
    Adv Ophthalmol Pract Res; 2024; 4(2):52-64. PubMed ID: 38586868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic Potential of Mesenchymal Stem Cell-Derived Exosomes in the Treatment of Eye Diseases.
    Harrell CR; Simovic Markovic B; Fellabaum C; Arsenijevic A; Djonov V; Arsenijevic N; Volarevic V
    Adv Exp Med Biol; 2018; 1089():47-57. PubMed ID: 29774506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Could donor multipotent mesenchymal stromal cells prevent or delay the onset of diabetic retinopathy?
    Ezquer F; Ezquer M; Arango-Rodriguez M; Conget P
    Acta Ophthalmol; 2014 Mar; 92(2):e86-95. PubMed ID: 23773776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Towards an Understanding of Retinal Diseases and Novel Treatment.
    Joachim SC
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35886925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Therapeutic Potential of Mesenchymal Stromal Cells in the Treatment of Chemotherapy-Induced Tissue Damage.
    Rühle A; Lopez Perez R; Zou B; Grosu AL; Huber PE; Nicolay NH
    Stem Cell Rev Rep; 2019 Jun; 15(3):356-373. PubMed ID: 30937640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.